Heart failure presents a growing public health problem both in Estonia and across Europe. At the same time, ...

GPT-Rosalind is OpenAI's first domain-specific model, built for drug discovery and life sciences—and it's not for everyone.

By comparing genetic data from 23 million newborns to rare disease models, researchers found some models’ estimates were 10 ...

AI thrives on data but feeding it the right data is harder than it seems. As enterprises scale their AI initiatives, they ...

Google used Cloud Next '26 to announce agent platforms, new TPUs, cross-cloud infrastructure, networking and data services aimed at AI workloads.

Getting a drug from initial target discovery to U.S. regulatory approval takes between 10 and 15 years on average. Most of ...

At Data Center World, Omdia analysts argued that the AI infrastructure buildout is no longer just a hyperscaler story. It is ...

The Credit Information Bureau of Sri Lanka (CRIB) is steering towards a major transformation in its data ecosystem, finalising plans to integrate telecommunications data by the end of this year, ...

At MWC 2026, Huawei released its AIDP. This platform integrates a knowledge base, KV cache acceleration, and a memory bank, and uses the Unified Cache Manager (UCM) to manage and schedule inference ...

10x Science has raised a $4.8 million seed round to help pharmaceutical researchers understand complex molecules.

OpenAI has unveiled GPT‑Rosalind, a new AI model focused on life sciences research. Named after Rosalind Franklin, the model ...

AI can deliver 5x--12x faster vector indexing and up to 57% lower token usage, as the company proves that the most effective path to AI efficiency runs through the data layer, not the GPU. WILMINGTON, ...